MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Is teleneurology effective in screening for spasticity?

K. Harper, B. Eoff, F. Phibbs, D. Isaacs, S. Gallion, E. Thomas, J. Scott, M. Hacker, D. Charles (Nashville, TN, USA)

Meeting: 2019 International Congress

Abstract Number: 1372

Keywords: Spasticity: Treatment

Session Information

Date: Tuesday, September 24, 2019

Session Title: Spasticity

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To test the effectiveness of teleneurology for spasticity screening.

Background: Spasticity is underdiagnosed and can pose significant problems when not treated. Unfortunately, according to a 2013 Association of American Medical Colleges Center for Workforce Studies report, the ratio of neurologists to patients in Tennessee is 1:28,567. Teleneurology is widely deployed to address the shortage of specialist physicians in community and rural settings. To test the effectiveness of utilizing teleneurology to screen for spasticity, movement disorders neurologists used hand-held technology facilitated by a bedside nurse to remotely screen for the signs or symptoms of spasticity in residents with intellectual disabilities residing in a long-term care facility.

Method: In-person examinations of residents (n=17) with intellectual disabilities residing in a long-term care facility were performed by a movement disorders neurologist to determine the presence of spasticity. After the in-person exam, two different movement disorders neurologists independently connected via telehealth technology to a bedside nurse facilitating an abbreviated screening examination for signs or symptoms suggesting the possible presence of spasticity.

Results: The two telehealth neurology examiners had a sensitivity of 73% and 82%, a negative predictive value (NPV) of 63% and 71%, and a specificity and positive predictive value (PPV) of 100% in the identification of spasticity. There was almost perfect agreement between the two telehealth neurologists (Kappa = 0.88, 95%CI 0.64-1.00). One participant withdrew consent and was not included in these analyses.

Conclusion: Screening patients with intellectual disabilities for spasticity utilizing teleneurology demonstrated high sensitivity and NPV, as well as perfect specificity and PPV. Our findings suggest that teleneurology is a reliable mechanism that could aid in identifying individuals who would benefit from referral for evaluation and treatment of spasticity. Additional research with a larger subject population is needed to validate these findings.

To cite this abstract in AMA style:

K. Harper, B. Eoff, F. Phibbs, D. Isaacs, S. Gallion, E. Thomas, J. Scott, M. Hacker, D. Charles. Is teleneurology effective in screening for spasticity? [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/is-teleneurology-effective-in-screening-for-spasticity/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/is-teleneurology-effective-in-screening-for-spasticity/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley